{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:05:54Z","timestamp":1791137154280,"version":"4.1.0"},"reference-count":35,"publisher":"Massachusetts Medical Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[1996,8,8]]},"DOI":"10.1056\/nejm199608083350602","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:52:53Z","timestamp":1027774373000},"page":"377-384","source":"Crossref","is-referenced-by-count":237,"title":["A Comparison of Two Regimens for the Treatment of<i>Mycobacterium avium<\/i>Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin"],"prefix":"10.1056","volume":"335","author":[{"given":"Stephen D.","family":"Shafran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Zarowny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Salit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignatius W.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. John","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita R.","family":"Rachlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Lalonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Fanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos M.","family":"Tsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"r001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CMR.6.3.266","volume":"6","author":"Inderlied CB","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"r002","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.1.7"},{"key":"r003","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.6.1082"},{"key":"r004","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.5.994"},{"key":"r005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1164\/ajrccm\/146.2.285","volume":"146","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"r006","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.4.801"},{"key":"r007","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-113-5-358","volume":"113","author":"Chiu J","year":"1990","journal-title":"Ann Intern Med"},{"key":"r008","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7326\/0003-4819-116-6-466","volume":"116","author":"Kemper CA","year":"1992","journal-title":"Ann Intern Med"},{"key":"r009","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.3_Pt_1.557"},{"key":"r010","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.152.4.813"},{"key":"r011","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.573"},{"key":"r012","first-page":"617","volume":"88","author":"Flegg PJ","year":"1995","journal-title":"Q J Med"},{"key":"r013","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.578"},{"key":"r014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7326\/0003-4819-121-12-199412150-00001","volume":"121","author":"Chaisson RE","year":"1994","journal-title":"Ann Intern Med"},{"key":"r015","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/AAC.37.11.2364","volume":"37","author":"Heifets L","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"r016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291202"},{"key":"r017","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.1.84"},{"key":"r018","unstructured":"Dautzenberg B, Ruf B, Esposito R, et al. Rifabutin vs placebo in combination therapy for the treatment of disseminated MAC in HIV+ patients. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla., October 4\u20137, 1994. Washington, D.C.: American Society for Microbiology, 1994:6. abstract."},{"key":"r019","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.1.157"},{"key":"r020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105093241906"},{"key":"r021","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.6.1326"},{"key":"r022","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L"},{"key":"r023","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199108000-00011"},{"key":"r024","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/JCM.26.6.1225-1226.1988","volume":"26","author":"Salfinger M","year":"1988","journal-title":"J Clin Microbiol"},{"key":"r025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402103300616"},{"key":"r026","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no. 32.)"},{"key":"r027","doi-asserted-by":"publisher","DOI":"10.2307\/2530245"},{"key":"r028","unstructured":"Shafran SD, Singer J, MAC Study Group. Uveitis in AIDS patients with MAC decreases markedly at lower rifabutin doses in combination with ethambutol and clarithromycin. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 17\u201320, 1995. Washington, D.C.: American Society for Microbiology, 1995:242. abstract."},{"key":"r029","first-page":"14","volume":"43","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"r030","unstructured":"May T, Brel F, Beuscart C, et al. A French randomized open trial of 2 clarithromycin combination therapies for MAC bacteremia: first results. In: Program and abstracts of the 35th Interscience Conferenceon Antimicrobial Agents and Chemotherapy, San Francisco, September 17\u201320, 1995. Washington, D.C.: American Society for Microbiology, 1995:11. abstract."},{"key":"r031","unstructured":"Chaisson RE, Benson CA, Dube M, et al. Clarithromycin therapy for disseminated Mycobacterium avium-complex (MAC) in AIDS. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, Calif., October 10\u201314, 1992. Washington, D.C.: American Society for Microbiology, 1992:259. abstract."},{"key":"r032","unstructured":"Cohn DL, Fisher E, Franchino B, et al. Comparison of two doses of clarithromycin in a randomized trial of four 3-drug regimens for treatment of disseminated Mycobacterium avium complex disease in AIDS: excess mortality associated with high-dose clarithromycin. Presented at the 11th International Conference on AIDS, Vancouver, B.C., July 7\u201312, 1996. abstract."},{"key":"r033","unstructured":"DATRI 001 Study Group. Clarithromycin (CL) plus rifabutin (RFB) for MAC prophylaxis: evidence for drug interaction. In: Abstracts of the First National Conference on Human Retroviruses and Related Infections, December 12\u201316, 1993. Washington, D.C.: American Society for Microbiology, 1994. abstract."},{"key":"r034","unstructured":"Idem. Coadministration of clarithromycin (CL) alters the concentration-time profile of rifabutin (RFB). In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla., October 4\u20137, 1994. Washington, D.C.: American Society for Microbiology, 1994:3. abstract."},{"key":"r035","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.3.747"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJM199608083350602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T12:11:38Z","timestamp":1583410298000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJM199608083350602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,8,8]]}},"alternative-id":["10.1056\/NEJM199608083350602"],"URL":"https:\/\/doi.org\/10.1056\/nejm199608083350602","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8,8]]}}}